Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines01:30

Cancer Vaccines

917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence01:22

Development of Immunocompetence

759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations01:51

Vaccinations

51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity01:07

Teratogenicity

3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Fate of Aortic Arch After Open Descending Thoracic and Thoracoabdominal Aortic Aneurysm Repair.

The Annals of thoracic surgery·2026
Same author

Isolated Endovascular Repair of the Ascending Aorta: Early Outcomes and Temporal Trends from a National Multicenter Registry.

Annals of vascular surgery·2026
Same author

Endoscopic vs. Operative Management of Acute Esophageal Perforation: A 21-Year Experience at a High-Volume Referral Center.

Seminars in thoracic and cardiovascular surgery·2026
Same author

Open Repair of Thoracoabdominal Aortic Aneurysms in the Endovascular Era: When and for Whom.

Journal of clinical medicine·2026
Same author

Standardized End Point Definitions for Clinical Trials in Thoracic Aortic Repair: A Consensus Report From the ARCH-Academic Research Consortium.

Circulation·2026
Same author

What Happens When a Third Option Enters a Two-Horse Race?

The Annals of thoracic surgery·2026

相关实验视频

Updated: Jan 6, 2026

Mitral Valve Prolapse III: Nursing Management
01:19

Mitral Valve Prolapse III: Nursing Management

Published on: June 19, 2025

252

转化生长因子-β受体II型的突变会导致家族胸前动脉动脉瘤和剖析.

Hariyadarshi Pannu1, Van Tran Fadulu, Jessica Chang

  • 1Department of Internal Medicine, Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX, USA.

Circulation
|July 20, 2005
PubMed
概括
此摘要是机器生成的。

转化生长因子-β受体II型 (TGFBR2) 基因的生殖基因突变与遗传性胸前动脉动脉瘤和剖析 (TAAD) 有关. 这些TGFBR2突变,特别是在460位,是家族性TAAD的重要原因.

更多相关视频

Cancer Vaccines
01:30

Cancer Vaccines

917
Development of Immunocompetence
01:22

Development of Immunocompetence

759

相关实验视频

Last Updated: Jan 6, 2026

Mitral Valve Prolapse III: Nursing Management
01:19

Mitral Valve Prolapse III: Nursing Management

Published on: June 19, 2025

252
Cancer Vaccines
01:30

Cancer Vaccines

917
Development of Immunocompetence
01:22

Development of Immunocompetence

759

科学领域:

  • 遗传学 是一个遗传学.
  • 心血管医学 心血管医学
  • 分子生物学分子生物学

背景情况:

  • 家庭胸前动脉动脉瘤和解剖 (TAAD) 具有遗传基础,以自体主导模式遗传.
  • 之前的研究已经确定了与家族性TAAD相关的染色体位置.
  • 转化生长因子-β受体II型 (TGFBR2) 的基因是研究的候选者.

研究的目的:

  • 调查TGFBR2基因突变是家族性TAAD的原因.
  • 为了确定是否发现的突变是TAAD遗传倾向的原因.

主要方法:

  • 测序TGFBR2基因所有8个编码外基因的序列.
  • 来自80个无关的家族TAAD病例的基因组DNA分析.
  • 对TGFBR2氨酸/氨酸激酶域的结构分析.

主要成果:

  • 在4个与家族TAAD无关的家族中发现了TGFBR2突变.
  • 所有突变都影响了细胞内域中的460位 (R460) 的氨酸,这表明一个突变热点.
  • 预计突变会干扰TGFBR2信号传导.

结论:

  • 胚胎TGFBR2突变占家族TAAD遗传倾向的5%.
  • TGFBR2突变是家族性TAAD的一个重要原因.
  • 这些发现突出了TGF-β信号在TAAD病理生理学中的作用.